| abstract |
The present invention is selected from the group consisting of cyclosporine as active ingredient, a mixture of propylene carbonate or propylene carbonate and polyethylene glycol as cosurfactant, esterified compound of fatty acid and monovalent alkanol as oil component, intermediate fatty acid triglyceride and monoglyceride A cyclosporin-containing soft capsule agent comprising a composition of a species oil or a mixture of two or more oils and a surfactant having an HLB value of 8 to 17. |